Abstract

Abstract:

The present invention relates to an improved process for the preparation of 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-6-[(2-hydroxyethoxy)carbamoyl]-1-methyl-1H benzimidazol-3-ium or a salt thereof, which is referred to as Selumetinib and represented by the following structural formulae,

Formula-1

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS